Did you see the CEO of Aegerion on CNBC this morni
Post# of 72440
Posted On: 01/23/2013 8:43:21 AM
Did you see the CEO of Aegerion on CNBC this morning? They just got their first drug approved for cholesterol for a market of potentially 6000 patients worldwide and expect first year sales of $75 million. They are up 70% in the past few months and trading at $27+.... can you imagine what CTIX will be at with KEVETRIN a success? Your $800+ might be in the ballpark!!!!
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼